FIRST ON FOX: Shortly after announcing a strategy to go after deceptive direct-to-consumer advertising by the pharmaceutical industry, Robert F. Kennedy Jr. and the Department of Health and Human ...

HHS Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary, MD, MPH, would seemingly like us to believe that they are strong-arming pharmaceutical companies into ending misleading marketing ...

In February 2014, the US Food and Drug Administration (FDA) announced that it wanted to revisit how it regulates the "major statement" of its drug advertisements, calling them potentially too long, ...

The bill would only prohibit direct-to-consumer advertising of approved prescription pharmaceuticals and biologics, sparing medical devices, dietary supplements, cosmetics, over-the-counter drugs, ...

(NewsNation) — The Food and Drug Administration launched a crackdown on misleading pharmaceutical advertising Tuesday, sending thousands of warning letters and approximately 100 cease-and-desist ...

President Donald Trump signed an order Tuesday aimed at tightening restrictions on direct-to-consumer drug advertising, expanding his administration’s scrutiny against big pharmaceutical companies and ...

The FDA is cracking down on misleading drug ads, issuing compliance and cease-and-desist letters to pharmaceutical companies. President Trump and HHS Secretary Kennedy emphasize transparency and ...

The US Food and Drug Administration (FDA) has published scores of warning letters, most of them to companies for marketing and advertising compounded versions of glucagon-like peptide-1 (GLP-1) ...

On September 9, 2025, the U.S. Food and Drug Administration (“FDA”) Office of Prescription Drug Promotion (“OPDP”) issued numerous untitled letters as part of the agency’s wider attack on direct to ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...